Bristol Myers Squibb (BMY) Dividends Paid - Common (2009 - 2026)
Bristol Myers Squibb's (BMY) quarterly Dividends Paid - Common came in at $1.3 billion in Q2 2026, up 1.98% year-over-year from $1.3 billion in Q2 2025, and little changed quarter-over-quarter from $1.3 billion in Q1 2026.
Analysis
Bristol Myers Squibb (BMY) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Bristol Myers Squibb (BMY) has reported Dividends Paid - Common for 18 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Dividends Paid - Common rose 1.98% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $5.1 billion, a 2.85% increase from a year earlier, with the FY2025 full-year figure at $5.0 billion, up 3.74% from the prior year.
- Dividends Paid - Common was $1.3 billion for Q2 2026 at Bristol Myers Squibb, roughly flat from $1.3 billion in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $1.3 billion in Q2 2026 and troughed at $12.0 million in Q2 2022.
- A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 frame the typical range for Dividends Paid - Common.
- The widest YoY moves for Dividends Paid - Common: up 9875.0% in 2023, down 0.93% in 2023.
- Over 5 years, Dividends Paid - Common stood at $1.1 billion in 2022, then increased by 1.31% to $1.2 billion in 2023, then increased by 5.0% to $1.2 billion in 2024, then advanced by 3.61% to $1.3 billion in 2025, then rose by 1.98% to $1.3 billion in 2026.
- The last three Dividends Paid - Common figures came in at $1.3 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -2.87 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 2.45 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 1.29 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 6.09 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | - |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.29 Bn |
| Mar 31, 2026 | 1.28 Bn |
| Dec 31, 2025 | 1.26 Bn |
| Sep 30, 2025 | 1.26 Bn |
| Jun 30, 2025 | 1.26 Bn |
| Mar 31, 2025 | 1.26 Bn |
| Dec 31, 2024 | 1.22 Bn |
| Sep 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.22 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Dec 31, 2023 | 1.16 Bn |
| Sep 30, 2023 | 1.19 Bn |
| Jun 30, 2023 | 1.20 Bn |
| Mar 31, 2023 | 1.20 Bn |
| Dec 31, 2022 | 1.15 Bn |
| Sep 30, 2022 | 1.15 Bn |
| Jun 30, 2022 | 12.00 Mn |
| Mar 31, 2022 | 1.19 Bn |
| Dec 31, 2021 | 1.10 Bn |
| Sep 30, 2021 | 1.09 Bn |